Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001600620-24-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-25 | 2024-11-21 | AUPH | Bailey Jeffrey Allen | Dir | A - Grant | $0.00 | +12.1K | 25.5K | +91% | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Bailey Jeffrey Allen | Dir | A - Grant | $0.00 | +18.6K | 18.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-11-21 | A | A | 12,135 | $0.00 | 25,491 | D | — | — | (F1) Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant. |
| 2 | Derivative | Director Stock Option (right to buy) | 2024-11-21 | A | A | 18,641 | $0.00 | 18,641 | D | $8.24 · — to 2034-11-21 | 18,641 Common Shares | (F2) The options shall vest one year from date of grant. |